14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Hypertrophy in 1 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
Excerpt | Relevance | Reference |
---|---|---|
"Hypertrophy is a major factor inducing proximal tubular epithelial cells injury." | 1.39 | 20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway. ( Eid, AA; Eid, S; Hamdy, A; Jaffa, AA; Maalouf, R; Nassif, J; Rashid, A; Ziyadeh, FN, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eid, S | 1 |
Maalouf, R | 1 |
Jaffa, AA | 1 |
Nassif, J | 1 |
Hamdy, A | 1 |
Rashid, A | 1 |
Ziyadeh, FN | 1 |
Eid, AA | 1 |
1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Hypertrophy
Article | Year |
---|---|
20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Blotting, Western; Cells, Cultured; Cytochrome P-450 CYP4A; Cy | 2013 |